Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Escalation of VP-16 With Cyclophosphamide and TBI for Autologous Transplantation in Lymphoma and ALL
NCT00004898Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Oct 1999
- Primary completion
- Jul 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of etoposide in lymphoma, acute lymphoblastic leukemia (ALL), sponsored by Northwestern University. Started Oct 1999; status: completed.
02
Drugs
etoposide
03
Conditions
lymphomaacute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00004898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004898.